Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoit Blanchet

Showing results (71-80 of 103) with videos related to

Pageof 11
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 14, 2025
Factors associated with medication adherence trajectory among patients treated with oral anticancer drugs: a multicentre cohort studyGermain Perrin, Audrey Thomas-Schoemann, François Goldwasser, et al.
Pharmaceutics|June 24, 2022
Relation between Plasma Trough Concentration of Pazopanib and Progression-Free Survival in Metastatic Soft Tissue Sarcoma PatientsMarie-Sophie Minot-This, Pascaline Boudou-Rouquette, Anne Jouinot, et al.
Fundamental & Clinical Pharmacology|September 12, 2018
Tacrolimus diffusion across the peripheral mononuclear blood cell membrane: impact of drug transportersCamille Tron, Marie Allard, Antoine Petitcollin, et al.
The Oncologist|April 1, 2026
Gastric and Rectal Administration of Encorafenib with Targeted Chemotherapy against BRAF V600E-Mutant Rectal Cancer with Bowel ObstructionMaximilian Alexander Funk, Volker Heinemann, Veit Bücklein, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2019
The impact of body composition parameters on severe toxicity of nivolumabLaure Hirsch, Audrey Bellesoeur, Pascaline Boudou-Rouquette, et al.
Bulletin Du Cancer|February 3, 2016
[Tyrosine kinase inhibiting the VEGF pathway and elderly people: Tolerance, pre-treatment assessment and side effects management]Marie Bretagne, Pascaline Boudou-Rouquette, Olivier Huillard, et al.
Clinical Therapeutics|July 8, 2020
Population Pharmacokinetics of Erlotinib in Patients With Non-small Cell Lung Cancer: Its Application for Individualized Dosing Regimens in Older PatientsEvelina Cardoso, Monia Guidi, Nihel Khoudour, et al.
Plos One|March 13, 2020
Pharmacogenetic-Whole blood and intracellular pharmacokinetic-Pharmacodynamic (PG-PK2-PD) relationship of tacrolimus in liver transplant recipientsCamille Tron, Jean-Baptiste Woillard, Pauline Houssel-Debry, et al.
Therapeutic Advances in Medical Oncology|April 26, 2024
Improving olaparib exposure to optimize adverse effects managementMarylise Sterlé, Alicja Puszkiel, Chloé Burlot, et al.
Fundamental & Clinical Pharmacology|October 22, 2017
Drug monitoring of sunitinib in patients with advanced solid tumors: a monocentric observational French studyLuc Cabel, Benoit Blanchet, Audrey Thomas-Schoemann, et al.
Pageof 11

Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 14, 2025
Factors associated with medication adherence trajectory among patients treated with oral anticancer drugs: a multicentre cohort studyGermain Perrin, Audrey Thomas-Schoemann, François Goldwasser, et al.
Pharmaceutics|June 24, 2022
Relation between Plasma Trough Concentration of Pazopanib and Progression-Free Survival in Metastatic Soft Tissue Sarcoma PatientsMarie-Sophie Minot-This, Pascaline Boudou-Rouquette, Anne Jouinot, et al.
Fundamental & Clinical Pharmacology|September 12, 2018
Tacrolimus diffusion across the peripheral mononuclear blood cell membrane: impact of drug transportersCamille Tron, Marie Allard, Antoine Petitcollin, et al.
The Oncologist|April 1, 2026
Gastric and Rectal Administration of Encorafenib with Targeted Chemotherapy against BRAF V600E-Mutant Rectal Cancer with Bowel ObstructionMaximilian Alexander Funk, Volker Heinemann, Veit Bücklein, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2019
The impact of body composition parameters on severe toxicity of nivolumabLaure Hirsch, Audrey Bellesoeur, Pascaline Boudou-Rouquette, et al.
Bulletin Du Cancer|February 3, 2016
[Tyrosine kinase inhibiting the VEGF pathway and elderly people: Tolerance, pre-treatment assessment and side effects management]Marie Bretagne, Pascaline Boudou-Rouquette, Olivier Huillard, et al.
Clinical Therapeutics|July 8, 2020
Population Pharmacokinetics of Erlotinib in Patients With Non-small Cell Lung Cancer: Its Application for Individualized Dosing Regimens in Older PatientsEvelina Cardoso, Monia Guidi, Nihel Khoudour, et al.
Plos One|March 13, 2020
Pharmacogenetic-Whole blood and intracellular pharmacokinetic-Pharmacodynamic (PG-PK2-PD) relationship of tacrolimus in liver transplant recipientsCamille Tron, Jean-Baptiste Woillard, Pauline Houssel-Debry, et al.
Therapeutic Advances in Medical Oncology|April 26, 2024
Improving olaparib exposure to optimize adverse effects managementMarylise Sterlé, Alicja Puszkiel, Chloé Burlot, et al.
Fundamental & Clinical Pharmacology|October 22, 2017
Drug monitoring of sunitinib in patients with advanced solid tumors: a monocentric observational French studyLuc Cabel, Benoit Blanchet, Audrey Thomas-Schoemann, et al.
Pageof 11